Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 1
2018 1
2019 1
2020 1
2021 5
2022 6
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Potential Effects on Elderly People From Nirsevimab Use in Infants.
Sanz-Muñoz I, Castrodeza-Sanz J, Eiros JM. Sanz-Muñoz I, et al. Open Respir Arch. 2024 Mar 23;6(2):100320. doi: 10.1016/j.opresp.2024.100320. eCollection 2024 Apr-Jun. Open Respir Arch. 2024. PMID: 38617129 Free PMC article. Review.
Association of viral loads of influenza A (H3N2) with age and care setting on presentation-a prospective study during the 2022-2023 influenza season in Spain.
Sanz-Muñoz I, Sánchez-Martínez J, Rodríguez-Crespo C, Arroyo-Hernantes I, Domínguez-Gil M, Rojo-Rello S, Hernández M, Eiros JM. Sanz-Muñoz I, et al. Int J Infect Dis. 2024 Jun;143:107034. doi: 10.1016/j.ijid.2024.107034. Epub 2024 Mar 30. Int J Infect Dis. 2024. PMID: 38561041 Free article.
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.
López-Lacort M, Muñoz-Quiles C, Mira-Iglesias A, López-Labrador FX, Mengual-Chuliá B, Fernández-García C, Carballido-Fernández M, Pineda-Caplliure A, Mollar-Maseres J, Shalabi Benavent M, Sanz-Herrero F, Zornoza-Moreno M, Pérez-Martín JJ, Alfayate-Miguelez S, Pérez Crespo R, Bastida Sánchez E, Menasalvas-Ruiz AI, Téllez-González MC, Esquiva Soto S, Del Toro Saravia C, Sanz-Muñoz I, Eiros JM, Matías Del Pozo V, Toquero-Asensi M, Pastor-Villalba E, Lluch-Rodrigo JA, Díez-Domingo J, Orrico-Sánchez A. López-Lacort M, et al. Among authors: sanz munoz i. Euro Surveill. 2024 Feb;29(6):2400046. doi: 10.2807/1560-7917.ES.2024.29.6.2400046. Euro Surveill. 2024. PMID: 38333937 Free PMC article.
Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010-2020 surveillance-based study.
García-Azorín D, Santana-López L, Lozano-Alonso JE, Ordax-Díez A, Vega-Alonso T, Macias Saint-Gerons D, González-Osorio Y, Rojo-Rello S, Eiros JM, Sánchez-Martínez J, Sierra-Mencía Á, Recio-García A, Martín-Toribio A, Sanz-Muñoz I, Guerrero-Peral ÁL. García-Azorín D, et al. Among authors: sanz munoz i. J Headache Pain. 2024 Feb 8;25(1):18. doi: 10.1186/s10194-024-01728-z. J Headache Pain. 2024. PMID: 38331709 Free PMC article.
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection.
Sánchez-de Prada L, Martínez-García AM, González-Fernández B, Gutiérrez-Ballesteros J, Rojo-Rello S, Garcinuño-Pérez S, Álvaro-Meca A, Ortiz De Lejarazu R, Sanz-Muñoz I, Eiros JM. Sánchez-de Prada L, et al. Among authors: sanz munoz i. Sci Rep. 2024 Jan 3;14(1):353. doi: 10.1038/s41598-023-50335-6. Sci Rep. 2024. PMID: 38172152 Free PMC article.
InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection.
García-Azorín D, Santana-López L, Lozano-Alonso JE, Ordax-Díez A, González-Osorio Y, Rojo-Rello S, Eiros JM, Sánchez-Martínez J, Recio-García A, Sierra-Mencía Á, Sanz-Muñoz I, Guerrero-Peral ÁL. García-Azorín D, et al. Among authors: sanz munoz i. Cephalalgia. 2023 Nov;43(11):3331024231212900. doi: 10.1177/03331024231212900. Cephalalgia. 2023. PMID: 37950674
Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults.
Sanz-Muñoz I, Lajara C, Sánchez-Martínez J, Prada-García C, Rojo-Rello S, Domínguez-Gil M, Fernández-Espinilla V, Hernán-García C, Eiros-Bachiller JM, Caminero-Pérez A, Marcos-López Y, Teso-Fernández L, Echarren JI, Castrodeza-Sanz J, Eiros JM. Sanz-Muñoz I, et al. Hum Vaccin Immunother. 2023 Aug 1;19(2):2236537. doi: 10.1080/21645515.2023.2236537. Hum Vaccin Immunother. 2023. PMID: 37528765 Free PMC article.
Old and new aspects of influenza.
Sanz-Muñoz I, Eiros JM. Sanz-Muñoz I, et al. Med Clin (Barc). 2023 Oct 13;161(7):303-309. doi: 10.1016/j.medcli.2023.06.004. Epub 2023 Jul 28. Med Clin (Barc). 2023. PMID: 37517930 Review. English, Spanish.
Group 1 and group 2 hemagglutinin stalk antibody response according to age.
Sánchez-de Prada L, Sanz-Muñoz I, Sun W, Palese P, Ortiz de Lejarazu R, Eiros JM, García-Sastre A, Aydillo T. Sánchez-de Prada L, et al. Among authors: sanz munoz i. Front Immunol. 2023 May 29;14:1194073. doi: 10.3389/fimmu.2023.1194073. eCollection 2023. Front Immunol. 2023. PMID: 37313413 Free PMC article.
32 results